Stocks · Korea
214390
KOSPI
Kyongbo Pharmaceutical
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER687.50x
PBR0.90x
EPS8 KRW
BPS6,096 KRW
ROE0.24%
Dividend yield0.91%
DPS50 KRW
Payout ratio625.00%
Returns and 52-week range
1W+0.55%
1M+1.48%
3M+4.17%
6M-28.01%
1Y-4.35%
YTD-3.51%
52W high9,300원
52W low4,700원
From 52W high-40.86%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 1,963억 | 14억 | 6억 | 0.7% |
| 2023 | 2,164억 | 55억 | 30억 | 2.6% |
| 2024 | 2,386억 | 105억 | 46억 | 4.4% |
| 2025 | 2,641억 | 35억 | 2억 | 1.3% |
| Quarterly | ||||
| 2024 4Q | 593억 | 30억 | 18억 | 5.0% |
| 2025 1Q | 606억 | 1억 | -7억 | 0.2% |
| 2025 2Q | 653억 | 24억 | -17억 | 3.7% |
| 2025 3Q | 670억 | 5억 | 30억 | 0.7% |
| 2025 4Q | 712억 | 5억 | -4억 | 0.7% |
| 2026 1Q | 661억 | 7억 | -5억 | 1.1% |
Company
Address: 충청남도 아산시 실옥로 174
Peers in the same sector
Recent filings
- 2026-09-30[기재정정]주요사항보고서(영업정지) Major
- 2026-08-31[기재정정]주요사항보고서(영업정지) Major
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
- 2026-03-18사업보고서 (2025.12)
- 2025-11-14분기보고서 (2025.09)
- 2025-08-14반기보고서 (2025.06)
- 2025-07-09[기재정정]주요사항보고서(영업정지) Major
- 2025-06-18[기재정정]주요사항보고서(영업정지) Major
- 2025-06-12주요사항보고서(영업정지) Major
Source: DART (Financial Supervisory Service electronic disclosure)
Recent news
- 2026-04-16[밸류업 점검] 경보제약, 배당성향 656% 착시…ADC 수익화 시험대 블로터
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.